3.9K
Reading Time: 2 minutes
INVASIVE MENINGOCOCCAL DISEASE (IMD)
Talk to your Healthcare Practitioner about preventative care from Sanofi.
SERIOUS, UNPREDICTABLE BACTERIAL INFECTION1
- Onset can be sudden1
- Early symptoms are non-specific (similar to flu-like symptoms)2,3
- Main forms of IMD2:
- Meningococcal Meningitis
Meningococcal Septicaemia
LIFE-THREATENING DISEASE1
- Can be difficult to diagnose4
- Rapidly progressive disease1
Death can occur in less than 24 hours4
LONG-TERM COMPLICATIONS1 · Survivors of IMD may suffer long-term disabilities1,5 · Hearing loss · Neurologic disabilities · Limb amputation |
REFERENCES:
- Taha MK, Bekkat-Berkani R, Abitbol V. Changing patterns of invasive meningococcal disease and future immunization strategies. Hum Vaccin Immunother. 2023;19(1):2186111. 2. National Institute of Communicable Diseases. Meningococcal Disease. An update for Healthcare Workers. April 2019. 3. Nadel S, Ninis N. Invasive Meningococcal Disease in the Vaccine Era. Front Pediatr. 2018;6(321):1-11. 4. Shaker R, Fayad D, et al. Challenges and opportunities for meningococcal vaccination in the developing world. Hum Vaccin Immunother. 2018;14(5):1084-1097. 5. Meiring S, Hussey G, et al. Recommendations for the use of meningococcal vaccines in South Africa. S Afr J Infect Dis. 2017;32(3):82-86. sanofi-aventis
YOU MAY ALSO LIKE
Rubella, commonly known as German measles, is a contagious viral infection primarily affecting children and young adults.
